Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.
Saved in:
| Title: | Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. |
|---|---|
| Authors: | Vellanki P; Division of Endocrinology, Metabolism, and Molecular Medicine (P.V., P.A.K., M.E.M.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; Georg-August University of Göttingen (K.L.), 37073 Göttingen, Germany; and Division of Endocrine Surgery (D.E.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611., Lange K, Elaraj D, Kopp PA, El Muayed M |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2014 Feb; Vol. 99 (2), pp. 387-90. Date of Electronic Publication: 2013 Oct 31. |
| Publication Type: | Case Reports; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
